CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Collaboration Combines CollPlant’s Proprietary rhCollagen-based BioInk Technology and United Therapeutics’ Regenerative Medicine and Organ Manufacturing Capabilities NESS ZIONA, Israel, November 12, 2018 -- (Healthcare Sales & Marketing Network) -- Col... Devices, Regenerative Medicine, Licensing CollPlant, United Therapeutics, Lung Biotechnology PBC, 3D bioprinting
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news